# Methylene Blue Against Falciparum Malaria in Burkina Faso

> **NCT02851108** · PHASE2 · COMPLETED · sponsor: **Heidelberg University** · enrollment: 100 (actual)

## Conditions studied

- Malaria, Falciparum

## Interventions

- **DRUG:** Methylene Blue
- **DRUG:** Primaquine

## Key facts

- **NCT ID:** NCT02851108
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2016-12
- **Final completion:** 2017-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02851108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02851108, "Methylene Blue Against Falciparum Malaria in Burkina Faso". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02851108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*